Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Human Vaccines Market Size Analysis from 2022 to 2027

1.5.1 Global Human Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Human Vaccines Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Human Vaccines Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Human Vaccines Industry Impact

Chapter 2 Global Human Vaccines Competition by Types, Applications, and Top Regions and Countries

2.1 Global Human Vaccines (Volume and Value) by Type

2.1.1 Global Human Vaccines Consumption and Market Share by Type (2016-2021)

2.1.2 Global Human Vaccines Revenue and Market Share by Type (2016-2021)

2.2 Global Human Vaccines (Volume and Value) by Application

2.2.1 Global Human Vaccines Consumption and Market Share by Application (2016-2021)

2.2.2 Global Human Vaccines Revenue and Market Share by Application (2016-2021)

2.3 Global Human Vaccines (Volume and Value) by Regions

2.3.1 Global Human Vaccines Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Human Vaccines Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Human Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Human Vaccines Consumption by Regions (2016-2021)

4.2 North America Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Human Vaccines Sales, Consumption, Export, Import (2016-2021)

4.10 South America Human Vaccines Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Human Vaccines Market Analysis

5.1 North America Human Vaccines Consumption and Value Analysis

5.1.1 North America Human Vaccines Market Under COVID-19

5.2 North America Human Vaccines Consumption Volume by Types

5.3 North America Human Vaccines Consumption Structure by Application

5.4 North America Human Vaccines Consumption by Top Countries

5.4.1 United States Human Vaccines Consumption Volume from 2016 to 2021

5.4.2 Canada Human Vaccines Consumption Volume from 2016 to 2021

5.4.3 Mexico Human Vaccines Consumption Volume from 2016 to 2021

Chapter 6 East Asia Human Vaccines Market Analysis

6.1 East Asia Human Vaccines Consumption and Value Analysis

6.1.1 East Asia Human Vaccines Market Under COVID-19

6.2 East Asia Human Vaccines Consumption Volume by Types

6.3 East Asia Human Vaccines Consumption Structure by Application

6.4 East Asia Human Vaccines Consumption by Top Countries

6.4.1 China Human Vaccines Consumption Volume from 2016 to 2021

6.4.2 Japan Human Vaccines Consumption Volume from 2016 to 2021

6.4.3 South Korea Human Vaccines Consumption Volume from 2016 to 2021

Chapter 7 Europe Human Vaccines Market Analysis

7.1 Europe Human Vaccines Consumption and Value Analysis

7.1.1 Europe Human Vaccines Market Under COVID-19

7.2 Europe Human Vaccines Consumption Volume by Types

7.3 Europe Human Vaccines Consumption Structure by Application

7.4 Europe Human Vaccines Consumption by Top Countries

7.4.1 Germany Human Vaccines Consumption Volume from 2016 to 2021

7.4.2 UK Human Vaccines Consumption Volume from 2016 to 2021

7.4.3 France Human Vaccines Consumption Volume from 2016 to 2021

7.4.4 Italy Human Vaccines Consumption Volume from 2016 to 2021

7.4.5 Russia Human Vaccines Consumption Volume from 2016 to 2021

7.4.6 Spain Human Vaccines Consumption Volume from 2016 to 2021

7.4.7 Netherlands Human Vaccines Consumption Volume from 2016 to 2021

7.4.8 Switzerland Human Vaccines Consumption Volume from 2016 to 2021

7.4.9 Poland Human Vaccines Consumption Volume from 2016 to 2021

Chapter 8 South Asia Human Vaccines Market Analysis

8.1 South Asia Human Vaccines Consumption and Value Analysis

8.1.1 South Asia Human Vaccines Market Under COVID-19

8.2 South Asia Human Vaccines Consumption Volume by Types

8.3 South Asia Human Vaccines Consumption Structure by Application

8.4 South Asia Human Vaccines Consumption by Top Countries

8.4.1 India Human Vaccines Consumption Volume from 2016 to 2021

8.4.2 Pakistan Human Vaccines Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Human Vaccines Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Human Vaccines Market Analysis

9.1 Southeast Asia Human Vaccines Consumption and Value Analysis

9.1.1 Southeast Asia Human Vaccines Market Under COVID-19

9.2 Southeast Asia Human Vaccines Consumption Volume by Types

9.3 Southeast Asia Human Vaccines Consumption Structure by Application

9.4 Southeast Asia Human Vaccines Consumption by Top Countries

9.4.1 Indonesia Human Vaccines Consumption Volume from 2016 to 2021

9.4.2 Thailand Human Vaccines Consumption Volume from 2016 to 2021

9.4.3 Singapore Human Vaccines Consumption Volume from 2016 to 2021

9.4.4 Malaysia Human Vaccines Consumption Volume from 2016 to 2021

9.4.5 Philippines Human Vaccines Consumption Volume from 2016 to 2021

9.4.6 Vietnam Human Vaccines Consumption Volume from 2016 to 2021

9.4.7 Myanmar Human Vaccines Consumption Volume from 2016 to 2021

Chapter 10 Middle East Human Vaccines Market Analysis

10.1 Middle East Human Vaccines Consumption and Value Analysis

10.1.1 Middle East Human Vaccines Market Under COVID-19

10.2 Middle East Human Vaccines Consumption Volume by Types

10.3 Middle East Human Vaccines Consumption Structure by Application

10.4 Middle East Human Vaccines Consumption by Top Countries

10.4.1 Turkey Human Vaccines Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Human Vaccines Consumption Volume from 2016 to 2021

10.4.3 Iran Human Vaccines Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Human Vaccines Consumption Volume from 2016 to 2021

10.4.5 Israel Human Vaccines Consumption Volume from 2016 to 2021

10.4.6 Iraq Human Vaccines Consumption Volume from 2016 to 2021

10.4.7 Qatar Human Vaccines Consumption Volume from 2016 to 2021

10.4.8 Kuwait Human Vaccines Consumption Volume from 2016 to 2021

10.4.9 Oman Human Vaccines Consumption Volume from 2016 to 2021

Chapter 11 Africa Human Vaccines Market Analysis

11.1 Africa Human Vaccines Consumption and Value Analysis

11.1.1 Africa Human Vaccines Market Under COVID-19

11.2 Africa Human Vaccines Consumption Volume by Types

11.3 Africa Human Vaccines Consumption Structure by Application

11.4 Africa Human Vaccines Consumption by Top Countries

11.4.1 Nigeria Human Vaccines Consumption Volume from 2016 to 2021

11.4.2 South Africa Human Vaccines Consumption Volume from 2016 to 2021

11.4.3 Egypt Human Vaccines Consumption Volume from 2016 to 2021

11.4.4 Algeria Human Vaccines Consumption Volume from 2016 to 2021

11.4.5 Morocco Human Vaccines Consumption Volume from 2016 to 2021

Chapter 12 Oceania Human Vaccines Market Analysis

12.1 Oceania Human Vaccines Consumption and Value Analysis

12.2 Oceania Human Vaccines Consumption Volume by Types

12.3 Oceania Human Vaccines Consumption Structure by Application

12.4 Oceania Human Vaccines Consumption by Top Countries

12.4.1 Australia Human Vaccines Consumption Volume from 2016 to 2021

12.4.2 New Zealand Human Vaccines Consumption Volume from 2016 to 2021

Chapter 13 South America Human Vaccines Market Analysis

13.1 South America Human Vaccines Consumption and Value Analysis

13.1.1 South America Human Vaccines Market Under COVID-19

13.2 South America Human Vaccines Consumption Volume by Types

13.3 South America Human Vaccines Consumption Structure by Application

13.4 South America Human Vaccines Consumption Volume by Major Countries

13.4.1 Brazil Human Vaccines Consumption Volume from 2016 to 2021

13.4.2 Argentina Human Vaccines Consumption Volume from 2016 to 2021

13.4.3 Columbia Human Vaccines Consumption Volume from 2016 to 2021

13.4.4 Chile Human Vaccines Consumption Volume from 2016 to 2021

13.4.5 Venezuela Human Vaccines Consumption Volume from 2016 to 2021

13.4.6 Peru Human Vaccines Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Human Vaccines Consumption Volume from 2016 to 2021

13.4.8 Ecuador Human Vaccines Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Human Vaccines Business

14.1 CNBG

14.1.1 CNBG Company Profile

14.1.2 CNBG Human Vaccines Product Specification

14.1.3 CNBG Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Walvax Biotechnology

14.2.1 Walvax Biotechnology Company Profile

14.2.2 Walvax Biotechnology Human Vaccines Product Specification

14.2.3 Walvax Biotechnology Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 ChengDa Bio

14.3.1 ChengDa Bio Company Profile

14.3.2 ChengDa Bio Human Vaccines Product Specification

14.3.3 ChengDa Bio Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Changsheng Life

14.4.1 Changsheng Life Company Profile

14.4.2 Changsheng Life Human Vaccines Product Specification

14.4.3 Changsheng Life Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Hissen

14.5.1 Hissen Company Profile

14.5.2 Hissen Human Vaccines Product Specification

14.5.3 Hissen Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Zhifei

14.6.1 Zhifei Company Profile

14.6.2 Zhifei Human Vaccines Product Specification

14.6.3 Zhifei Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 SANOFI

14.7.1 SANOFI Company Profile

14.7.2 SANOFI Human Vaccines Product Specification

14.7.3 SANOFI Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 SINOVAC BIOTECH

14.8.1 SINOVAC BIOTECH Company Profile

14.8.2 SINOVAC BIOTECH Human Vaccines Product Specification

14.8.3 SINOVAC BIOTECH Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Kangtai

14.9.1 Kangtai Company Profile

14.9.2 Kangtai Human Vaccines Product Specification

14.9.3 Kangtai Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 GSK

14.10.1 GSK Company Profile

14.10.2 GSK Human Vaccines Product Specification

14.10.3 GSK Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Changchun Baike

14.11.1 Changchun Baike Company Profile

14.11.2 Changchun Baike Human Vaccines Product Specification

14.11.3 Changchun Baike Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Rong An

14.12.1 Rong An Company Profile

14.12.2 Rong An Human Vaccines Product Specification

14.12.3 Rong An Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Adimmune

14.13.1 Adimmune Company Profile

14.13.2 Adimmune Human Vaccines Product Specification

14.13.3 Adimmune Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Tiantan biological

14.14.1 Tiantan biological Company Profile

14.14.2 Tiantan biological Human Vaccines Product Specification

14.14.3 Tiantan biological Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 NuoCheng Bio

14.15.1 NuoCheng Bio Company Profile

14.15.2 NuoCheng Bio Human Vaccines Product Specification

14.15.3 NuoCheng Bio Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.16 Zhongyianke Biotech

14.16.1 Zhongyianke Biotech Company Profile

14.16.2 Zhongyianke Biotech Human Vaccines Product Specification

14.16.3 Zhongyianke Biotech Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.17 Hualan Bio

14.17.1 Hualan Bio Company Profile

14.17.2 Hualan Bio Human Vaccines Product Specification

14.17.3 Hualan Bio Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Human Vaccines Market Forecast (2022-2027)

15.1 Global Human Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Human Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Human Vaccines Value and Growth Rate Forecast (2022-2027)

15.2 Global Human Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Human Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Human Vaccines Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Human Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Human Vaccines Consumption Forecast by Type (2022-2027)

15.3.2 Global Human Vaccines Revenue Forecast by Type (2022-2027)

15.3.3 Global Human Vaccines Price Forecast by Type (2022-2027)

15.4 Global Human Vaccines Consumption Volume Forecast by Application (2022-2027)

15.5 Human Vaccines Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology